Epirubicin: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Epirubicin. Educational only — not medical advice.
Labeled uses
ELLENCE is indicated as a component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer [see Clinical Studies (14.1) ] .
Source: FDA labeling via NIH DailyMed (set 0a03c798…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.